Clinical Trial

Comparison of Clinical Efficacy of Submucosal Dexamethasone and Oral Trypsin-chymotrypsin for Reduction of Postoperative Sequelae After Lower Third Molar Surgery

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 3, 2024 (before its estimated December 25, 2024 completion). Its status may not reflect the trial's current state.
Summary
Pain, edema and trismus are the most frequent postoperative sequelae to surgical removal of impacted teeth, all of are due to the local inflammatory response. Use of corticosteroids decrease tissue mediators of inflammation and reduce edema. Use of trypsin-chymotrypsin elaborates the enzymes esterase in blood plasma that inhibits inflammation by hydrolytic degradation of the inflammatory peptides.
Trial Details
NCT Number NCT06713733
Lead Sponsor B.P. Koirala Institute of Health Sciences
Conditions Clinical Efficacy of Submucosal Dexamethasone and Oral Trypsin Chymotrypsin for Reduction of Postoperative Sequelae After Lower Third Molar Surgery
Enrollment 50 participants
Start Date 2024-09-25
Primary Completion 2024-12-25 (estimated)
Study Completion 2025-01-25 (estimated)
Updated on ClinicalTrials.gov 2024-12-03